Darrow Company’s Humana HUM Stock Holding History

Darrow Company’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-453	Closed	-$207K	–	46
2023 Q4	$207K	Buy	+453	New	+$223K	0.16%	36

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Darrow Company's HUM Position: Q1 2024 in Review

Darrow Company sold out of Humana (HUM) in Q1 2024, closing a stake of 453 shares — an estimated $207K sold.

Darrow Company first reported a position in HUM in Q4 2023 and held it in 1 quarter. The position peaked at $207K in Q4 2023. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

Darrow Company reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
Darrow Company sold 453 Humana shares in Q1 2024, an estimated $207K.
Darrow Company first reported a position in Humana in Q4 2023 and held it in 1 quarter.
Darrow Company's Humana position peaked at $207K in Q4 2023.
1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Darrow Company's 13F filing for Q1 2024, filed 1 May 2024.